12-111214215-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000261726.11(CUX2):c.79G>A(p.Val27Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000261 in 1,496,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V27F) has been classified as Likely benign.
Frequency
Consequence
ENST00000261726.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CUX2 | NM_015267.4 | c.79G>A | p.Val27Ile | missense_variant | 2/22 | ENST00000261726.11 | NP_056082.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CUX2 | ENST00000261726.11 | c.79G>A | p.Val27Ile | missense_variant | 2/22 | 1 | NM_015267.4 | ENSP00000261726 | P1 | |
CUX2 | ENST00000397643.3 | c.259G>A | p.Val87Ile | missense_variant | 3/8 | 1 | ENSP00000380765 |
Frequencies
GnomAD3 genomes AF: 0.0000147 AC: 2AN: 136194Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.00000989 AC: 2AN: 202220Hom.: 0 AF XY: 0.00000899 AC XY: 1AN XY: 111174
GnomAD4 exome AF: 0.0000272 AC: 37AN: 1360578Hom.: 0 Cov.: 28 AF XY: 0.0000296 AC XY: 20AN XY: 674578
GnomAD4 genome AF: 0.0000147 AC: 2AN: 136194Hom.: 0 Cov.: 30 AF XY: 0.0000154 AC XY: 1AN XY: 64932
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | Jul 10, 2023 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 29, 2021 | The c.79G>A (p.V27I) alteration is located in exon 2 (coding exon 2) of the CUX2 gene. This alteration results from a G to A substitution at nucleotide position 79, causing the valine (V) at amino acid position 27 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at